AzTrials
AzTrials

Anxiety DisordersNOVA IIINCT01296321

Tailored Internet-administrated Treatment of Panic Symptoms - A Randomised Controlled Trial

A study testing Tailored Internet-administrated CBT-Treatment and Waitlist in people with Anxiety Disorders and Depression, run by Linkoeping University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of panic symptoms and comorbid anxiety and depressive symptoms. Read more about this study

Who is it for?
Ages 18 to 45 years
Conditions the study is for
Anxiety Disorders, Depression
What is being tested?
Tailored Internet-administrated CBT-Treatment and Waitlist
Could I receive a placebo?
No, everyone receives an active treatment
How many people
57 participants
Where
No sites listed yet
Study dates
Feb 2010to Apr 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Be between the ages of 18-30 years old or 31-46 years old
  • Have reoccurring panic attacks

Who cannot join

  • Suicide prone
  • Alcohol addiction
  • PTSD
  • OCD
  • Ongoing psychological treatment

About this study

The purpose of this study is to determine whether tailored internet-administrated CBT is a feasible approach in the treatment of panic symptoms and comorbid anxiety and depressive symptoms.

Being tested
Tailored Internet-administrated CBT-Treatment, Waitlist
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Tailored Internet-administrated CBT-TreatmentBehavioural

    This intervention contains 6-8 text-based self-help modules in which 4 modules are fixed (the first three and the last) and the rest are "prescribed following the diagnostic telephone interview. These modules contain material on panic disorder, social phobia, stress management, assertiveness training, concentration, relaxation among other things.

  • WaitlistBehavioural

    Passive waitlist during 8-10 weeks.

Study groups in NCT01296321
Study groupRoleWhat they receive
Tailored Internet-delivered CBTExperimentalBehavioral: Tailored Internet-delivered CBT
Receives: Behavioral: Tailored Internet-administrated CBT-Treatment
WaitlistActive comparatorWaitlist.
Receives: Behavioral: Waitlist

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Panic Disorder Severity Scale (PDSS)

    Change from baseline in panic symptoms two weeks post treatment, at six months and at 12 months post treatment.

    Measured: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment

Secondary outcomes (4)
  1. Clinical Outcome in Routine Evaluation - Outcome Measure (CORE-OM)

    Change from baseline in anxiety and depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.

    Measured: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment

  2. Beck Anxiety Inventory (BAI)

    Change from baseline in anxiety symptoms two weeks post treatment, at six months and at 12 months post treatment.

    Measured: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment

  3. Montgomery Åsberg Depression Rating Scale-Self Rated (MADRS-S)

    Change from baseline in depressive symptoms two weeks post treatment, at six months and at 12 months post treatment.

    Measured: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment

  4. Quality of Life Inventory (QOLI)

    Change from baseline in quality of life statements two weeks post treatment, at six months and at 12 months post treatment.

    Measured: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2011 (estimated)
  2. Study startFeb 2010
  3. Primary completionApr 2011 (estimated)
  4. Study completionApr 2011 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
57 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01296321
Sponsor's protocol ID
GA-FAS-2008-1145
Acronym
NOVA III
Status last verified
Feb 2011
First submitted
14 Feb 2011
Last updated
16 Feb 2011
Results posted
No

Publications

  • Silfvernagel K, Carlbring P, Kabo J, Edstrom S, Eriksson J, Manson L, Andersson G. Individually tailored internet-based treatment for young adults and adults with panic attacks: randomized controlled trial. J Med Internet Res. 2012 Jun 26;14(3):e65. doi: 10.2196/jmir.1853.

    PubMed 22732098

Questions about this trial

What is this clinical trial studying?

A study testing Tailored Internet-administrated CBT-Treatment and Waitlist in people with Anxiety Disorders and Depression, run by Linkoeping University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Panic Disorder Severity Scale (PDSS) (time frame: Two weeks pre treatment, two weeks post treatment, six months and 12 months post treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01296321, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in